The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer.
Tomoyuki TatenumaTakashi KawaharaNarihiko HayashiHisashi HasumiKazuhide MakiyamaNoboru NakaigawaTakeshi KishidaYasuhide MiyoshiMasahiro YaoHiroji UemuraPublished in: BioMed research international (2019)
The higher NLR group showed a significantly poorer OS than the lower NLR group. Pre-DOC NLR might be a new marker for predicting the prognosis of patients who receive DOC chemotherapy.